Kroger Co. (0JS2)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 63.84 |
|---|---|
| 52-week range | 53.35 – 76.06 |
| Return, 1 month / 3 months | +7.9% / +15.2% |
| Return, 1 year / 3 years | −5.3% / +52.9% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 29.0% |
| Worst drawdown (1 year) | -26.0% |
| Average daily value traded | 0.30M USD |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kroger is an American grocery retailer that runs supermarkets and multi-department stores across the United States. Its stores sell food and drink, fresh produce, pharmacy items, household goods and general merchandise, and many sites include fuel centres and pickup or delivery services. The company serves everyday household shoppers through several regional store banners and also operates its own food production and private-label brands. Kroger is based in Cincinnati, Ohio.
On this site Kroger Co. appears as a stock on the London Exchange (UK), code 0JS2, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kroger Co. (0JS2) trades on the London Exchange in UK. It last closed at USD 63.84 on 21 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,934 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.3% and over the last three months it rose 15.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 1.6% | ||
| From 52-week high | -14.4% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 15.2% | ||
| 6-month return | -6.0% | ||
| 12-month return, skipping the last month | -12.2% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.0% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.30M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | +7.9% |
| 3 months | +15.2% |
| 6 months | −6.0% |
| 1 year | −5.3% |
| 3 years | +52.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 59.36 / 62.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.42 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.3900 |
| 15 May 2026 | USD 0.3500 |
| 12 Feb 2026 | USD 0.3500 |
| 13 Nov 2025 | USD 0.3500 |
| 14 Aug 2025 | USD 0.3500 |
| 14 May 2025 | USD 0.3200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.